Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc

Bullboard Posts

Comment by Stocktreeon Oct 05, 2016 4:18pm

94 Views

Post# 25313703

RE:Spectral's Material Charge Report on sedar.com

Thanks Josh.

This is complete BS. There was never, as SWYG mentioned many times, a pre specified population of 243 patients. Never. This is a lie. I could well understand that they tried to enlarge the 176 population to get better results, but it is a lie that it was pre specified (or they lied to us earlier).

The rest is BS too. All other end-points are not numbered and compared to anything. The mortality improved, but they won't say it because they have on paper that it is not statistically material (enough). Why would the other benefits be? Nothing hard.

Bullboard Posts

NervGen Pharma: Proof that NVG-291 works?